These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9651732)

  • 61. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension.
    Kailasam MT; Parmer RJ; Cervenka JH; Wu RA; Ziegler MG; Kennedy BP; Adegbile IA; O'Connor DT
    Hypertension; 1995 Jul; 26(1):143-9. PubMed ID: 7607717
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Central sympathoinhibitory effects of calcium channel blockers.
    Leenen FH; Ruzicka M; Huang BS
    Curr Hypertens Rep; 2001 Aug; 3(4):314-21. PubMed ID: 11470014
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of cilnidipine on insulin sensitivity in patients with essential hypertension.
    Yagi S; Goto S; Yamamoto T; Kurihara S; Katayama S
    Hypertens Res; 2003 May; 26(5):383-7. PubMed ID: 12887129
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ankle oedema and sympathetic activation.
    Fogari R
    Drugs; 2005; 65 Suppl 2():21-7. PubMed ID: 16398059
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Critical assessment of calcium antagonists.
    Krum H
    Aust Fam Physician; 1997 Jul; 26(7):841-5, 847-8. PubMed ID: 9232924
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Calcium channel antagonists: friend or foe in postinfarction patients?
    Gibson RS; Boden WE
    Am J Hypertens; 1996 Dec; 9(12 Pt 2):172S-176S. PubMed ID: 8968429
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Calcium antagonists in cardiovascular diseases--a valuable controversy, but unnecessary panic].
    Messerli FH
    Ther Umsch; 1999 Jan; 56(1):43-8. PubMed ID: 10067134
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Blood pressure regulation in pheochromocytoma.
    Bravo EL; Tarazi RC; Fouad FM; Textor SC; Gifford RW; Vidt DG
    Hypertension; 1982; 4(3 Pt 2):193-9. PubMed ID: 7040238
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Effect of total flavones of Hippophae rhamnoides L. on sympathetic activity in hypertension].
    Zhang X; Zhang M; Gao Z; Wang J; Wang Z
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):547-50. PubMed ID: 12528545
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The calcium antagonist controversy: a posthumous commentary.
    Messerli FH; Grossman E
    Am J Cardiol; 1998 Nov; 82(9B):35R-39R. PubMed ID: 9822143
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evidences supporting an increased sympathetic tone and reactivity in a subgroup of patients with essential hypertension.
    de Champlain J; Cousineau D; Lapointe L
    Clin Exp Hypertens (1978); 1980; 2(3-4):359-77. PubMed ID: 7428561
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical pharmacological evaluation of calcium antagonists and other drugs modifying myogenic tone in essential hypertension.
    Reid JL; Donnelly R; Meredith PA; Elliott HL
    J Hypertens Suppl; 1989 Sep; 7(4):S169-71. PubMed ID: 2681593
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relations between blood pressure and plasma norepinephrine concentrations after administration of diltiazem to rats: HPLC-peroxyoxalate chemiluminescence determination on an individual basis.
    Higashidate S; Imai K; Prados P; Adachi-Akahane S; Nagao T
    Biomed Chromatogr; 1994; 8(1):19-21. PubMed ID: 8130627
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dihydropyridines and beta-adrenoceptor antagonists as combination treatment in hypertension.
    MacCarthy EP
    J Hypertens Suppl; 1987 Dec; 5(4):S133-7. PubMed ID: 2894418
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Elevated plasma norepinephrine during cyclopropane anesthesia as a possible function of decreased amine metabolism.
    Gardier RW; Reier CE; Traber DL; Rowe HM; Hamelberg W
    Anesth Analg; 1967; 46(6):800-5. PubMed ID: 6070171
    [No Abstract]   [Full Text] [Related]  

  • 76. 1,4-Dihydropyridines versus beta-blockers for hypertension: are either safe for the heart?
    Leenen FH
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):397-402. PubMed ID: 8924051
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effects of verapamil SR and bisoprolol on reducing the sympathetic nervous system's activity.
    Sun N; Hong T; Zhang R; Yang X
    Hypertens Res; 2000 Sep; 23(5):537-40. PubMed ID: 11016810
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [ Sensitivity of alpha- and betareceptors in patients with hypertension].
    Komor K; Décsy J; Herpai Z; Krassói A; Vass I; Simonyi J
    Z Kreislaufforsch; 1970 Sep; 59(9):805-13. PubMed ID: 5460456
    [No Abstract]   [Full Text] [Related]  

  • 79. Can we use calcium antagonist better in antihypertensive therapy? Circadian consideration.
    Zhang W
    Pharmacol Res; 1996; 34(5-6):187-91. PubMed ID: 9076842
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Calcium antagonist treatment, sympathetic activity and platelet function.
    Hjemdahl P; Wallén NH
    Eur Heart J; 1997 Jan; 18 Suppl A():A36-50. PubMed ID: 9049538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.